Empowered Funds LLC Takes Significant Stake in Amgen Inc.
Empowered Funds LLC acquired a new stake in Amgen Inc. (NASDAQ:AMGN) during the second quarter, as reported in its latest Form 13F filing with the SEC.
The institutional investor purchased approximately 95,907 shares of Amgen's stock, valued at about $34.73 million.
Amgen's commercial portfolio includes therapies such as Ozempic, Mounjaro, Wegovy, and Zepbound, among others.